The amniotic fluid-derived cells: the biomedical challenge for the third millennium

Area of Science:

• Reproductive Biology
• Cell Biology
• Regenerative Medicine

Background:

• Human amniotic fluid cells (H-AFC) have a long-standing history, over 50 years, in prenatal diagnosis.
• Hematopoietic progenitors were identified in amniotic fluid in the early 1990s, expanding understanding of H-AFC.
• Recent discoveries suggest H-AFC possess therapeutic potential for various human diseases.

Purpose of the Study:

• To provide a historical overview of human amniotic fluid cells (H-AFC).
• To highlight key scientific advancements regarding H-AFC.
• To present recent evidence on the therapeutic potential of H-AFC.

Main Methods:

• Literature review of studies on human amniotic fluid cells.
• Analysis of historical data and recent scientific publications.
• Synthesis of findings on H-AFC applications in diagnostics and therapeutics.

Main Results:

• H-AFC established as a diagnostic tool for fetal genetic anomalies for over five decades.
• Identification of hematopoietic progenitors in amniotic fluid in the 1990s.
• Emerging evidence in the last five years indicates therapeutic potential of H-AFC.

Conclusions:

• Human amniotic fluid cells (H-AFC) have evolved from purely diagnostic tools to potential therapeutic agents.
• The therapeutic applications of H-AFC represent a significant recent advancement in the field.
• Further research into H-AFC is warranted to explore their full therapeutic capabilities.